Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
JXSL1600040	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Import Drug Application	2016-07-11	Bayer Healthcare LLC	Certificate Issued	2018-07-27	view
JYSB2000431	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2020-09-03		Certificate Issued	2020-10-27	view
JYSB1900243	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2019-09-05		Filed	2019-09-16	view
JXSS2200005	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-01-26				view
JXSL0900046	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Import Drug Application	2009-07-01	Bayer Healthcare LLC	Certificate Issued	2011-01-19	view
JYSZ1600015	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2016-05-10		Certificate Issued	2017-04-19	view
JYSB1800202	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2018-09-29		Certificate Issued	2019-06-04	view
JYSB2101160	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-10				view
JYSB1800056	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2018-03-28		Filed	2018-04-13	view
JYSB2101029	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-05-12	Bayer Healthcare LLC			view
JYSB2400051	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2024-03-07				view
JYSB1600273	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2017-01-03		Certificate Issued	2017-04-10	view
JYSB2000568	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2020-11-18		Filed	2020-12-01	view
JYSB2300180	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2023-10-26				view
JXSS1000008	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Import Drug Application	2010-09-15		Certificate Issued	2012-08-28	view
JYSB1900085	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2019-04-24		Certificate Issued	2019-10-30	view
JYSB2200064	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2022-04-08	Novo Nordisk A/S			view
JYSB1500126	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2015-05-08		Certificate Issued	2015-08-12	view
JYSZ1800031	注射用重组人凝血因子Ⅷ	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	License Renew	2018-07-20	Bayer Healthcare LLC	Certificate Issued	2019-06-03	view
JYSB2101162	注射用重组人凝血因子VIII	Recombinant Coagulation Factor Ⅷ	Lyophilized	Biological Products	Supplementary Application	2021-11-10				view